Bon Natural Life Limited
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M | $18.2M | $16.4M |
| Cost of Revenue | $14.8M | $16.7M | $20.7M | $20.5M | $18.4M | $13.0M | $11.1M |
| Gross Profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M | $5.2M | $5.3M |
| Gross Margin | 20.8% | 29.8% | 29.9% | 31.5% | 27.9% | 28.6% | 32.2% |
| Operating Expenses | |||||||
| Research & Development | $754.2K | $1.6M | $298.5K | $424.6K | $249.1K | $205.4K | $522.9K |
| SG&A Expense | $4.3M | $3.3M | $2.3M | $2.2M | $1.3M | $1.4M | $1.3M |
| Operating Income | $-1.6M | $1.9M | $5.9M | $6.6M | $5.4M | $3.5M | $3.2M |
| Operating Margin | -8.7% | 7.9% | 20.1% | 22.1% | 21.2% | 19.0% | 19.4% |
| Interest Expense | $366.2K | $303.3K | $238.2K | $446.9K | $417.3K | $329.1K | $333.2K |
| Pretax Income | $-1.7M | $715.9K | $5.6M | $7.6M | $5.4M | $3.7M | $3.0M |
| Income Tax Expense | $339.4K | $351.2K | $1.0M | $1.3M | $820.9K | $556.3K | $427.2K |
| Net Income | $-2.0M | $398.2K | $4.6M | $6.2M | $4.6M | $3.0M | $2.6M |
| Net Margin | -10.7% | 1.7% | 15.6% | 20.9% | 18.0% | 16.6% | 15.7% |
| EPS (Basic) | $-0.72 | $0.14 | $1.45 | $0.09 | $0.01 | $0.01 | $0.01 |
| EPS (Diluted) | $-0.72 | $0.14 | $1.44 | $0.09 | $0.01 | $0.01 | $0.01 |
| Shares Outstanding (Basic) | 2.8M | 2.8M | 3.2M | 72.7M | 575.6M | 453.3M | 449.5M |
| Shares Outstanding (Diluted) | 2.8M | 2.8M | 3.2M | 73.0M | 583.4M | 453.3M | 449.5M |
| Dividends Per Share | — | — | — | — | — | — | — |